COVID-19 has delayed at least 100,000 surgeries in Canada, including up to 30 percent of cancer-related surgeries such as tissue biopsies. Currently, surgery backlogs are estimated to be 1-2 years across the country. Circulating tumor DNA (ctDNA) testing has been found to be an effective alternative to some surgical tissue biopsies to guide cancer targeted […]
Canexia Health
New Funding To Accelerate Canexia Health’s Precision Oncology Roadmap
Canexia Health has raised a new financing round from PacBridge Capital Partners to support the company’s long-term global growth and accelerate its roadmap to make cancer testing for treatment selection and monitoring accessible to all cancer patients. The amount of the funding round was not disclosed. Formerly known as Contextual Genomics, Canexia makes high-quality cancer […]
Canexia Health To Offer Cancer Testing and Treatment During COVID-19
Cancer patients have an estimated two-fold increased risk of contracting COVID-19 and a three-fold risk of dying compared to the general population. Since early March, COVID-19 has delayed or postponed at least 100,000 surgeries in Canada including cancer tissue biopsies. A comprehensive approach is required to address the needs of this high-risk group to limit […]